Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.

Activation of YAP/TAZ in bone marrow niche cells accelerates hematopoietic regeneration after myeloablative stress, with a notable enhancement in recovery.

• Why it matters: Restoring the bone marrow niche is crucial for effective hematopoietic recovery, yet current therapeutic options are limited, especially after injury caused by myeloablative treatments.
• What they did: The study used pharmacological activation of YAP/TAZ in endothelial and mesenchymal stromal cells, demonstrating rapid activation post-injury and its role in maintaining niche cell identity and promoting vascular remodeling.
• The result: YAP/TAZ activation improved niche reorganization and hematopoietic regeneration, suggesting that targeting these pathways offers a promising approach to enhance recovery following hematopoietic injury.